The RESTING Insomnia Study: Randomized Controlled Study on Effectiveness of Stepped-Care Sleep Therapy
RESTING
Randomized Controlled Study of the Effectiveness of Stepped-Care Sleep Therapy In General Practice
2 other identifiers
interventional
388
1 country
1
Brief Summary
This project aims to compare the effectiveness and implementation potential of two primary care friendly approaches to delivering an effective non-pharmacological intervention - cognitive behavioral therapy - for insomnia to middle aged and older adults.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Feb 2019
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 1, 2018
CompletedFirst Posted
Study publicly available on registry
May 22, 2018
CompletedStudy Start
First participant enrolled
February 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 12, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
January 12, 2023
CompletedResults Posted
Study results publicly available
December 19, 2024
CompletedDecember 19, 2024
December 1, 2024
3.9 years
May 1, 2018
December 9, 2024
December 17, 2024
Conditions
Outcome Measures
Primary Outcomes (2)
Insomnia Severity Index (ISI)
The ISI is an empirically validated 7-item questionnaire, with each item rated on a 0 to 4 scale. The score is the sum of the 7 items. scores range between 0 and 28 (higher score corresponds with greater insomnia severity), with 10 as a cutoff score for identifying individuals in the community who are likely to meet criteria for insomnia disorder and 8 as a cutoff for defining remission.
at baseline and at months 2, 4, 6, 9, & 12
Use of Prescription Sleep Medication
The average number of minimal effective doses of prescription sleep medications taken; A greater number means that the person was taking number of minimal effective doses of prescription sleep medications, with a value of 0 meaning that the person is not taking any prescription sleep medication.
at baseline and at months 2, 4, 6, 9, & 12
Secondary Outcomes (2)
Patient-Reported Outcomes Measurement Information System (PROMIS) - Sleep Related Impairment Questionnaire
at baseline and at months 2, 4, 6, 9, & 12
PHQ-4 (The 4 Item Patient Health Questionnaire For Anxiety and Depression)
at baseline and at months 2, 4, 6, 9, & 12
Study Arms (2)
ONLINE ONLY
ACTIVE COMPARATOROnline cognitive behavioral therapy for insomnia
STEPPED CARE
EXPERIMENTALCognitive behavioral therapy for insomnia online or therapist-led or sequentially both
Interventions
A two step treatment that starts with either an online or therapist led cognitive behavioral therapy for insomnia, depending on a decision algorithm (checklist). Those with insufficient progress to the online treatment after 8 weeks are switched to a therapist-led treatment
Eligibility Criteria
You may qualify if:
- insomnia disorder
You may not qualify if:
- Unable to be consented in English without an interpreter
- In poor physical or mental that limits capacity to participate in study treatment (e.g., Mini-Mental State Examination score \< 25)
- Unable to use the internet
- Study physician determines participation is not medically advised for any reason
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Stanford Universitylead
- National Institute on Aging (NIA)collaborator
Study Sites (1)
Stanford University
Palo Alto, California, 94305, United States
Related Publications (3)
Manber R, Gumport NB, Tully IA, Kim JP, Kim B, Simpson N, Rosas LG, Zulman DM, Goldhaber-Fiebert JD, Rangel E, Dietch JR, Tutek J, Palaniappan L. Effects of a Triage Checklist to optimize insomnia treatment outcomes and reduce hypnotic use: the RCT of the effectiveness of stepped-care sleep therapy in general practice study. Sleep. 2025 Jan 13;48(1):zsae182. doi: 10.1093/sleep/zsae182.
PMID: 39115347RESULTTully IA, Kim JP, Simpson N, Palaniappan L, Tutek J, Gumport NB, Dietch JR, Manber R. Beliefs about prescription sleep medications and interest in reducing hypnotic use: an examination of middle-aged and older adults with insomnia disorder. J Clin Sleep Med. 2023 Jul 1;19(7):1247-1257. doi: 10.5664/jcsm.10552.
PMID: 36883379DERIVEDManber R, Tully IA, Palaniappan L, Kim JP, Simpson N, Zulman DM, Goldhaber-Fiebert JD, Rangel E, Dietch JR, Rosas LG. RCT of the effectiveness of stepped-care sleep therapy in general practice: The RESTING study protocol. Contemp Clin Trials. 2022 May;116:106749. doi: 10.1016/j.cct.2022.106749. Epub 2022 Mar 30.
PMID: 35367385DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Rachel Manber, PhD
- Organization
- Stanford University
Study Officials
- PRINCIPAL INVESTIGATOR
Rachel Manber, PhD
Stanford University
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Participants are asked to refrain from mentioning any information about the treatment they receive when interacting with the investigator or outcomes assessors
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
May 1, 2018
First Posted
May 22, 2018
Study Start
February 1, 2019
Primary Completion
January 12, 2023
Study Completion
January 12, 2023
Last Updated
December 19, 2024
Results First Posted
December 19, 2024
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF
- Time Frame
- Data will become available 2 years after the publication of the results pertaining to the primary aims. Data will be available for 2 years after its release
- Access Criteria
- Data will be shared only with investigators who have a clear and rigorous analytic plan and who sign a data use agreement with Stanford University.
The researchers will share fully de-identified data on: the two primary outcomes, allocation to arm, and demographic.